This content is machine translated Severe asthma and psoriasis Biologics combination leads to success Biologics are now established treatment options, particularly for severe courses of the disease. However, there is little data on the the efficacy and safety of simultaneous administration of several biologics…
View Post 8 min This content is machine translated BPH-associated LUTS complaints Sabal-Urtica combination relieves symptoms and has few side effects A review summarized the results from four randomized placebo- or reference-controlled double-blind trials of a Sabal-Urtica combination preparation in men over 50 years of age with BPH-associated LUTS. The phytopreparation…
View Post 5 min This content is machine translated Hidradenitis suppurativa Treatment options – status quo and outlook The management of hidradenitis suppurativa remains a clinical challenge. A combination of different therapeutic modalities is often required to achieve a sufficient degree of disease control. One study demonstrated that…
View Post 4 min This content is machine translated 28th German Skin Cancer Congress 2018, Stuttgart Update on immunotherapy of malignant melanoma Combination immunotherapy, adjuvant immune checkpoint blockade, and long-term survival after PD-1 inhibitor therapy were the topics of two satellite symposia at the German Skin Cancer Congress.
View Post 3 min This content is machine translated Newly diagnosed multiple myeloma Does a proteasome inhibitor offer new therapeutic options? One study discussed at the ASH meeting involved a regimen consisting of oral MLN9708 administered twice weekly plus lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma. It concludes…
View Post 3 min This content is machine translated Aliskiren Good blood pressure control in combination with HCT Aliskiren, a renin inhibitor that reduces the amount of angiotensin II, is available as a monotherapy (Rasilez®) and in combination with hydrochlorothiazide (Rasilez HCT®). Recent real-world studies and meta-analyses confirm…
View Post 4 min This content is machine translated Highlights of the symposium at the Inselspital Bern How to respond to cervical cancer in pregnancy? The twelfth annual symposium of the Breast and Tumor Center at the Inselspital Bern, which was held at the end of December 2013, focused this time on cervical carcinoma. What…
View Post 4 min This content is machine translated Metastatic renal cell carcinoma. What are the reasons for resistance to current drugs? Practical strategies for treatment management of metastatic renal cell carcinoma (mRCC) were presented at the ESMO Congress in Amsterdam. Updates on current clinical trials and the utility of new treatment…
View Post 5 min This content is machine translated Pancreatic adenocarcinoma The “borderline resectable” tumors as a specific challenge. At ASCO-GI in San Francisco, one of the topics was pancreatic adenocarcinoma. The so-called “borderline resectable” tumors were of particular interest. It is up for discussion whether primary surgery is…
View Post 4 min This content is machine translated Treatment of metastatic colorectal carcinoma. Patients with RAS wild type benefit in overall survival New data on first-line treatment of metastatic colorectal cancer were presented at the ASCO GI in San Francisco. The post-hoc analyses consistently confirm that RAS mutation status is an important…
